Abstract
Hemifacial spasm (HFS) is characterized by unilateral involuntary rapid and repetitive facial contractions, which interfere with the individual’s daily activities and social interactions. HFS is most frequently caused by compression of facial nerve at the root entry zone by an ectatic vessel. Differential diagnosis includes other etiologies (i.e., post-Bell’s palsy synkinesis, posterior fossa space-occupying lesions) and HFS mimics (i.e., blepharospasm and psychogenic movement disorders). Diagnosis is primarily clinical but may require imaging to rule out nonvascular etiologies (brain MRI) and to localize the nature and site of the vessel compression (brain MRA). Treatment of choice is botulinum toxin injections every 3–6 months. Surgical decompression has a high rate of success but may result in permanent complications (deafness, facial paralysis) in a small number of cases.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Case
The patient is a 36-year-old man, working at high managerial and customer relation levels, who started noticing bothersome contractions of the left lower eyelid. His past medical history included an inguinal hernia, obstructive sleep apnea under control with oral appliance (no obesity), right rotator cuff tear, and dyslipidemia. His only medication was atorvastatin. He had no history of Bell’s palsy .
Exam disclosed synchronous brief contractions of the left lower eyelid that would come in flurries in a spontaneous fashion and that would not cause palpebral fissure closure. The rest of his neurological examination was unremarkable.
It was initially thought this abnormal movement represented either eyelid myokymia or early hemifacial spasm. Injections with botulinum toxin were initiated with success. Over the ensuing months, eyelid contractions were associated with partial palpebral fissure closure and a few months later with left mid-cheek contraction.
MRI of the brain including MRA revealed a tortuous and ectatic left distal vertebral artery that impinged and posteriorly displaced the root entry zone of the left cranial nerves 7/8 complex and mild mass effect on the left hypoglossal and left abducens nerves. Neurovascular surgery consultations were obtained, but the patient preferred to continue receiving botulinum toxin injections every 4–6 months, which have provided excellent relief.
Discussion
Hemifacial spasm (HFS) is a syndrome of partial or complete and painless involuntary contractions of one side of the face. The movements come on spontaneously or are triggered by facial movements (smiling, lip pursing) or emotion. The contractions can be sustained (tonic) or brief and repetitive (clonic). HFS can rarely be bilateral (less than 5%), in which case contractions on one side are asynchronous with the ones on the other side.
Prevalence of HFS is 11 per 100,000 persons. HFS affects individuals of all ages with a peak in the middle age. There is female preponderance (M/F: 1/2). The only acknowledged risk factor is hypertension. Rare familial cases have been reported. A less vigorous association has been postulated with migraine and trigeminal neuralgia.
HFS may start as a very restricted phenomenon, such as lower eyelid twitch, as seen in our patient, before it extends to the rest of the face. HFS is a stand-alone movement disorder , and it should not be accompanied by any symptom outside facial symptomatology, and there are no sensory features.
HFS originates in the transition zone of central and peripheral myelin or the more proximal root entry zone of the seventh cranial nerve, where it is being compressed by an aberrant or tortuous loop of a vessel of the vertebrobasilar system. The most common culprit vessels are the anterior-inferior cerebellar artery (AICA) , the posterior-inferior cerebellar artery (PICA) , and the vertebral artery. HFS, therefore, belongs to the family of neurovascular compressive syndromes that also include trigeminal neuralgia, glossopharyngeal neuralgia, and vestibular nerve compression syndrome (postulated as a potential cause of dizziness and vertigo). The vessel pressure generates ectopic firing in the facial nerve or hyperexcitability of the facial motor nucleus.
Other etiologies of HFS are much less common. They include cerebellopontine angle tumors, brain stem gliomas, multiple sclerosis, and CNS vascular insults. A very small number are familial, but the genetic abnormality is unknown.
HFS requires differentiation from other facial dyskinesias , especially facial synkinesis following Bell’s palsy and other facial nerve injuries (trauma, surgery). A key distinguishing feature of HFS is its spontaneous contractions as opposed to the tight triggering by voluntary facial movements seen with facial synkinesis . HFS mimics include psychogenic hemifacial spasm, craniofacial dystonia (blepharospasm, orofacial dystonia, oromandibular dystonia), facial tic, facial myokymia, hemi-masticatory spasm, and oculomasticatory myorhythmia.
Diagnosis may begin and end with the clinical exam if the clinician feels comfortable with an otherwise typical presentation and where surgical decompression is not being entertained in the near future. Magnetic resonance imaging of the brain can be done if the clinician is concerned about nonvascular etiologies, while brain MRA may pinpoint the culprit vessel and the site of compression. It is not unusual that only at the time of neurovascular surgery can the compression be visualized. Cerebral angiography is only needed if surgery is seriously being considered and is required for surgical planning.
Our patient had clear evidence of vertebrobasilar dolichoectasia specifically of the left vertebral artery. Of interest was his substantially younger age than most reported cases (mean age in the 50s), which raises the question of other predisposing factors (genetic, small posterior cranial fossa) that might be of academic interest to pursue but that would have no bearing on treatment at this time.
Botulinum toxin injections represent the treatment of choice with a high rate of success (85–95%) accompanied by a low rate of reversible complications (ptosis, facial weakness). Repeat injections are usually required every 3–6 months.
I inject subcutaneously in four sites around the involved eye with doses between 1.25 and 5 units of onabotulinumtoxinA (or other neurotoxin equivalents). Two sites are located in the tarsal portion of the upper eyelid, one site in the lateral canthus and one site in the outer half of the lower eyelid. I might also inject additional sites including the corrugator and the midface (zygomaticus complex, nasalis, risorius) as well as the perioral muscles and mentalis (see Fig. 75.1).
Oral pharmacology with carbamazepine, clonazepam, baclofen, and gabapentin is notoriously disappointing. Surgery represents the only chance for a permanent solution. Under general anesthesia, a retrosigmoid craniotomy is performed, and a Teflon sponge is placed between the vessel and the facial nerve. Figures of recurrence are in the low single digits, but there are risks of temporary or permanent deafness and or facial paralysis (also in the single digits).
Suggested Reading
Haller S, Etienne L, Kovari E, Varoqquaux AD, Urbach H, Becker M. Imaging of neurovascular compression syndromes trigeminal neuralgia, Hemifacial spasm, vestibular Paroxysmia and glossopharyngeal neuralgia. AJNR Am J Neuroradiol. 2016;37:1384.
Kim KJ, Kim J-M, Bae YJ, Bae HJ, Jeon B, Kim JH, Han JH, Oh CW. The association between vertebrobasilar dolichoectasia and hemifacial spasm. Parkinsonism Relat Disord. 2016;30:1–6.
Papapetropoulos S, Argyriou AA, Guevara A, Sengun C, Mitsi G, Singer C. Hemifacial spasm and pontine compression caused by a giant vertebrobasilar dolichoectasia. Cerebrovasc Dis. 2009;27:413–4.
Rosenstengel C, Matthes M, Baldauf J, Fleck S, Schroeder H. Hemifacial spasm conservative and surgical treatment options. Dtsch Atztebl Int. 2012;109(41):667–73.
Yaltho TC, Jankovic J. The many faces of Hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011;26(9):1582–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Singer, C. (2019). Treatment of Hemifacial Spasm. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_75
Download citation
DOI: https://doi.org/10.1007/978-3-319-97897-0_75
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-97896-3
Online ISBN: 978-3-319-97897-0
eBook Packages: MedicineMedicine (R0)